Hotline:
86-023-62505954
中文版 /
English
Home
About Us
Introduction
Company History
Management Team
Honor and Certification
Organization
R&D
Team
Facilities
Innovative drug R&D
ANDA R&D
Product&Service
Technical service
Clinincal CRO
Product and Manufacture
Compliance
Quality Management
Registration
Q&A
News
Company news
Industry News
Company Notice
Company Culture
Corporate Philosophy
Our Staff
Resource
Contact
Contact Details
News
News
Company news
Industry News
Company Notice
Contact Us
/ contact us
If you want to consult products, call us：
TEL:
86-023-62505954
FAX:
86-023-62512066
E-mail:
cpri@cpri.com.cn
Your location：
Home
→
News
→
Industry News
To be added...
日期：
2013-12-11
浏览次数:
31
To be added...
Prev：None
Next：None
Related News：
/
Related News：
More
Press Release_CPRI_BMGF
2018
-
08
-
23
Chongqing Pharmaceutical Research Institute Co., Ltd. has received funding from the Bill & Melinda Gates Foundation for the development of a large-scale semi-synthetic Artemisinin processIn July 2018, Chongqing Pharmaceutical Research Institute Co., Ltd (“CPRI”), the Research and Development platform of Fosun Pharma, was awarded with 450,000 USD from the Bill & Melinda Gates Foundation (“G...
More
To be added...
2013
-
12
-
11
To be added...
More
To be added...
2017
-
03
-
09
To be added...
More
【
Close Window
】【
Print
】
About Us
Introduction
Company History
Management Team
Honor and Certification
Organization
R&D
Team
Facilities
Innovative drug R&D
ANDA R&D
Product&Service
Technical service
Clinincal CRO
Product and Manufacture
Compliance
Quality Management
Registration
Q&A
News
Company news
Industry News
Company Notice
Company Culture
Corporate Philosophy
Our Staff
Resource
Contact
Contact Details
Contact Us
No.565 · NanAnDistrict · ChongQing
Tel： 86-023-62505954
86-023062505956
E-mail：cpri@cpri.com.cn
Copyright ©2005 - 2013
Chongqing Pharmaceutical Research Institute
渝ICP备18002359号
Sitemap
犀牛云提供企业云服务
Sweep phone website